Frassetto LA et al. |
Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipients. |
2007 |
Am. J. Transplant. |
pmid:17949460
|
Cavadas PC et al. |
Bilateral trans-humeral arm transplantation: result at 2 years. |
2011 |
Am. J. Transplant. |
pmid:21521475
|
Singh K et al. |
Superiority of rapamycin over tacrolimus in preserving nonhuman primate Treg half-life and phenotype after adoptive transfer. |
2014 |
Am. J. Transplant. |
pmid:25359003
|
Dugast E et al. |
Failure of Calcineurin Inhibitor (Tacrolimus) Weaning Randomized Trial in Long-Term Stable Kidney Transplant Recipients. |
2016 |
Am. J. Transplant. |
pmid:27367750
|
Tang Q |
Pharmacokinetics of therapeutic Tregs. |
2014 |
Am. J. Transplant. |
pmid:25358900
|
Wen X et al. |
Comparison of Utilization and Clinical Outcomes for Belatacept- and Tacrolimus-Based Immunosuppression in Renal Transplant Recipients. |
2016 |
Am. J. Transplant. |
pmid:27137884
|
Sikma MA et al. |
Pharmacokinetics and Toxicity of Tacrolimus Early After Heart and Lung Transplantation. |
2015 |
Am. J. Transplant. |
pmid:26053114
|
Ellis CL and Racusen LC |
Mild rise in creatinine six months post kidney transplant. |
2012 |
Am. J. Transplant. |
pmid:22845913
|
English RF et al. |
Long-term comparison of tacrolimus- and cyclosporine-induced nephrotoxicity in pediatric heart-transplant recipients. |
2002 |
Am. J. Transplant. |
pmid:12243498
|
de Fontbrune FS et al. |
Veno-occlusive disease of the liver after lung transplantation. |
2007 |
Am. J. Transplant. |
pmid:17697264
|
Abdelmalek MF et al. |
Sirolimus conversion regimen versus continued calcineurin inhibitors in liver allograft recipients: a randomized trial. |
2012 |
Am. J. Transplant. |
pmid:22233522
|
Krenzien F et al. |
Age-Dependent Metabolic and Immunosuppressive Effects of Tacrolimus. |
2017 |
Am. J. Transplant. |
pmid:27754593
|
Zafrani L et al. |
Incidence, risk factors and clinical consequences of neutropenia following kidney transplantation: a retrospective study. |
2009 |
Am. J. Transplant. |
pmid:19538494
|
Touzot M et al. |
Renal transplantation in HIV-infected patients: the Paris experience. |
2010 |
Am. J. Transplant. |
pmid:20840478
|
Krämer BK et al. |
Tacrolimus once daily (ADVAGRAF) versus twice daily (PROGRAF) in de novo renal transplantation: a randomized phase III study. |
2010 |
Am. J. Transplant. |
pmid:20840480
|
TruneÄka P et al. |
Once-daily prolonged-release tacrolimus (ADVAGRAF) versus twice-daily tacrolimus (PROGRAF) in liver transplantation. |
2010 |
Am. J. Transplant. |
pmid:20840481
|
Gupta G et al. |
Safe Conversion From Tacrolimus to Belatacept in High Immunologic Risk Kidney Transplant Recipients With Allograft Dysfunction. |
2015 |
Am. J. Transplant. |
pmid:25988397
|
Ekberg H et al. |
Calcineurin inhibitor minimization in the Symphony study: observational results 3 years after transplantation. |
2009 |
Am. J. Transplant. |
pmid:19563339
|
Wang Q et al. |
Biodegradable microsphere-loaded tacrolimus enhanced the effect on mice islet allograft and reduced the adverse effect on insulin secretion. |
2004 |
Am. J. Transplant. |
pmid:15084166
|
Schubert M et al. |
Pharmacokinetics of sirolimus and tacrolimus in pediatric transplant patients. |
2004 |
Am. J. Transplant. |
pmid:15084173
|
ter Meulen CG et al. |
Steroid-withdrawal at 3 days after renal transplantation with anti-IL-2 receptor alpha therapy: a prospective, randomized, multicenter study. |
2004 |
Am. J. Transplant. |
pmid:15084178
|
Borrows R et al. |
Steroid sparing with tacrolimus and mycophenolate mofetil in renal transplantation. |
2004 |
Am. J. Transplant. |
pmid:15476485
|
Hernández-Fisac I et al. |
Tacrolimus-induced diabetes in rats courses with suppressed insulin gene expression in pancreatic islets. |
2007 |
Am. J. Transplant. |
pmid:17725683
|
Suszynski TM et al. |
Prospective randomized trial of maintenance immunosuppression with rapid discontinuation of prednisone in adult kidney transplantation. |
2013 |
Am. J. Transplant. |
pmid:23432755
|
Budde K et al. |
Sotrastaurin, a novel small molecule inhibiting protein kinase C: first clinical results in renal-transplant recipients. |
2010 |
Am. J. Transplant. |
pmid:20121745
|
Damon C et al. |
Predictive Modeling of Tacrolimus Dose Requirement Based on High-Throughput Genetic Screening. |
2017 |
Am. J. Transplant. |
pmid:27597269
|
Shuker N et al. |
A Randomized Controlled Trial Comparing the Efficacy of Cyp3a5 Genotype-Based With Body-Weight-Based Tacrolimus Dosing After Living Donor Kidney Transplantation. |
2016 |
Am. J. Transplant. |
pmid:26714287
|
Al-Massarani G et al. |
Impact of immunosuppressive treatment on endothelial biomarkers after kidney transplantation. |
2008 |
Am. J. Transplant. |
pmid:18925903
|
MacPhee IA et al. |
The influence of pharmacogenetics on the time to achieve target tacrolimus concentrations after kidney transplantation. |
2004 |
Am. J. Transplant. |
pmid:15147425
|
Artz MA et al. |
Conversion from cyclosporine to tacrolimus improves quality-of-life indices, renal graft function and cardiovascular risk profile. |
2004 |
Am. J. Transplant. |
pmid:15147428
|
Hirsch HH et al. |
Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study. |
2013 |
Am. J. Transplant. |
pmid:23137180
|
Mujtaba MA et al. |
Conversion from tacrolimus to belatacept to prevent the progression of chronic kidney disease in pancreas transplantation: case report of two patients. |
2014 |
Am. J. Transplant. |
pmid:25179306
|
Flechner SM et al. |
Allotransplantation of cryopreserved parathyroid tissue for severe hypocalcemia in a renal transplant recipient. |
2010 |
Am. J. Transplant. |
pmid:20883540
|
BenÃtez CE et al. |
ATG-Fresenius treatment and low-dose tacrolimus: results of a randomized controlled trial in liver transplantation. |
2010 |
Am. J. Transplant. |
pmid:20883560
|
Böger CA et al. |
Reverse diastolic intrarenal flow due to calcineurin inhibitor (CNI) toxicity. |
2006 |
Am. J. Transplant. |
pmid:16889550
|
Shihab FS et al. |
Effect of corticosteroid withdrawal on tacrolimus and mycophenolate mofetil exposure in a randomized multicenter study. |
2013 |
Am. J. Transplant. |
pmid:23167508
|
Tan HP et al. |
Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy. |
2006 |
Am. J. Transplant. |
pmid:16889606
|
Alloway RR et al. |
A randomized pharmacokinetic study of generic tacrolimus versus reference tacrolimus in kidney transplant recipients. |
2012 |
Am. J. Transplant. |
pmid:22759200
|
Hesselink DA et al. |
Cyclosporine interacts with mycophenolic acid by inhibiting the multidrug resistance-associated protein 2. |
2005 |
Am. J. Transplant. |
pmid:15816878
|
Byrne GW et al. |
Warfarin or low-molecular-weight heparin therapy does not prolong pig-to-primate cardiac xenograft function. |
2005 |
Am. J. Transplant. |
pmid:15816881
|
Lucey MR et al. |
A comparison of tacrolimus and cyclosporine in liver transplantation: effects on renal function and cardiovascular risk status. |
2005 |
Am. J. Transplant. |
pmid:15816894
|
Pillebout E et al. |
Renal histopathological lesions after orthotopic liver transplantation (OLT). |
2005 |
Am. J. Transplant. |
pmid:15816895
|
Arnold R et al. |
Association between calcineurin inhibitor treatment and peripheral nerve dysfunction in renal transplant recipients. |
2013 |
Am. J. Transplant. |
pmid:23841745
|
Hirsch HH et al. |
BK Polyomavirus Replication in Renal Tubular Epithelial Cells Is Inhibited by Sirolimus, but Activated by Tacrolimus Through a Pathway Involving FKBP-12. |
2016 |
Am. J. Transplant. |
pmid:26639422
|
Muthusamy AS et al. |
Alemtuzumab induction and steroid-free maintenance immunosuppression in pancreas transplantation. |
2008 |
Am. J. Transplant. |
pmid:18828772
|
Van Laecke S et al. |
Posttransplantation hypomagnesemia and its relation with immunosuppression as predictors of new-onset diabetes after transplantation. |
2009 |
Am. J. Transplant. |
pmid:19624560
|
Pescovitz MD et al. |
A randomized, double-blind, pharmacokinetic study of oral maribavir with tacrolimus in stable renal transplant recipients. |
2009 |
Am. J. Transplant. |
pmid:19663892
|
Shergill AK et al. |
Applicability, tolerability and efficacy of preemptive antiviral therapy in hepatitis C-infected patients undergoing liver transplantation. |
2005 |
Am. J. Transplant. |
pmid:15636619
|
Tydén G et al. |
ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab. |
2005 |
Am. J. Transplant. |
pmid:15636623
|
Woodle ES et al. |
A multicenter pilot study of early (4-day) steroid cessation in renal transplant recipients under simulect, tacrolimus and sirolimus. |
2005 |
Am. J. Transplant. |
pmid:15636625
|
Mian AN et al. |
Mycoplasma hominis septic arthritis in a pediatric renal transplant recipient: case report and review of the literature. |
2005 |
Am. J. Transplant. |
pmid:15636628
|
Gregoor PS and Weimar W |
Tacrolimus and pure red-cell aplasia. |
2005 |
Am. J. Transplant. |
pmid:15636632
|
Gao R et al. |
Effects of immunosuppressive drugs on in vitro neogenesis of human islets: mycophenolate mofetil inhibits the proliferation of ductal cells. |
2007 |
Am. J. Transplant. |
pmid:17391142
|
Tremblay S et al. |
A Steady-State Head-to-Head Pharmacokinetic Comparison of All FK-506 (Tacrolimus) Formulations (ASTCOFF): An Open-Label, Prospective, Randomized, Two-Arm, Three-Period Crossover Study. |
2017 |
Am. J. Transplant. |
pmid:27340950
|
Neuberger JM et al. |
Delayed introduction of reduced-dose tacrolimus, and renal function in liver transplantation: the 'ReSpECT' study. |
2009 |
Am. J. Transplant. |
pmid:19120077
|
Momper JD et al. |
The impact of conversion from prograf to generic tacrolimus in liver and kidney transplant recipients with stable graft function. |
2011 |
Am. J. Transplant. |
pmid:21714845
|
Tan HP et al. |
Two hundred living donor kidney transplantations under alemtuzumab induction and tacrolimus monotherapy: 3-year follow-up. |
2009 |
Am. J. Transplant. |
pmid:19120078
|
Ashman N et al. |
Belatacept as maintenance immunosuppression for postrenal transplant de novo drug-induced thrombotic microangiopathy. |
2009 |
Am. J. Transplant. |
pmid:19120084
|
Lemahieu WP et al. |
CYP3A4 and P-glycoprotein activity in healthy controls and transplant patients on cyclosporin vs. tacrolimus vs. sirolimus. |
2004 |
Am. J. Transplant. |
pmid:15307840
|
Vongwiwatana A et al. |
Peritubular capillary changes and C4d deposits are associated with transplant glomerulopathy but not IgA nephropathy. |
2004 |
Am. J. Transplant. |
pmid:14678043
|
Bressollette-Bodin C et al. |
A prospective longitudinal study of BK virus infection in 104 renal transplant recipients. |
2005 |
Am. J. Transplant. |
pmid:15996241
|
De Simone P et al. |
Everolimus with reduced tacrolimus in liver transplantation. |
2013 |
Am. J. Transplant. |
pmid:23601137
|
Fan DM et al. |
Successful ABO-incompatible living-related intestinal transplantation: a 2-year follow-up. |
2015 |
Am. J. Transplant. |
pmid:25808777
|
Luther P and Baldwin D |
Pioglitazone in the management of diabetes mellitus after transplantation. |
2004 |
Am. J. Transplant. |
pmid:15575920
|
Cherukuri A et al. |
An analysis of lymphocyte phenotype after steroid avoidance with either alemtuzumab or basiliximab induction in renal transplantation. |
2012 |
Am. J. Transplant. |
pmid:22390816
|
Dahm F et al. |
Conversion from cyclosporine to tacrolimus improves quality-of-life indices, renal graft function and cardiovascular risk profile. |
2004 |
Am. J. Transplant. |
pmid:15575921
|
Pascher A et al. |
Protein kinase C inhibitor sotrastaurin in de novo liver transplant recipients: a randomized phase II trial. |
2015 |
Am. J. Transplant. |
pmid:25677074
|
Chen G et al. |
A synergistic effect between PG490-88 and tacrolimus prolongs renal allograft survival in monkeys. |
2006 |
Am. J. Transplant. |
pmid:16539628
|
Okabayashi T et al. |
Mobilization of host stem cells enables long-term liver transplant acceptance in a strongly rejecting rat strain combination. |
2011 |
Am. J. Transplant. |
pmid:21883903
|
Hellemons ME et al. |
Former smoking is a risk factor for chronic kidney disease after lung transplantation. |
2011 |
Am. J. Transplant. |
pmid:21883906
|
Servais A et al. |
Interstitial fibrosis evolution on early sequential screening renal allograft biopsies using quantitative image analysis. |
2011 |
Am. J. Transplant. |
pmid:21672152
|
Mulay AV et al. |
Impact of immunosuppressive medication on the risk of renal allograft failure due to recurrent glomerulonephritis. |
2009 |
Am. J. Transplant. |
pmid:19353768
|
Mazariegos GV et al. |
Dendritic cell subset ratio in tolerant, weaning and non-tolerant liver recipients is not affected by extent of immunosuppression. |
2005 |
Am. J. Transplant. |
pmid:15643991
|
Bahra M et al. |
MMF and calcineurin taper in recurrent hepatitis C after liver transplantation: impact on histological course. |
2005 |
Am. J. Transplant. |
pmid:15644002
|
Ryan CM and Swanson DP |
clinical research, innovative practice and IRB review: identifying and respecting boundaries. |
2007 |
Am. J. Transplant. |
pmid:17331113
|
Montgomery SP et al. |
Efficacy and toxicity of a protocol using sirolimus, tacrolimus and daclizumab in a nonhuman primate renal allotransplant model. |
2002 |
Am. J. Transplant. |
pmid:12118862
|
Ahsan N et al. |
Limited dose monoclonal IL-2R antibody induction protocol after primary kidney transplantation. |
2002 |
Am. J. Transplant. |
pmid:12118902
|
van Hooff JP et al. |
Glucose metabolic disorder after transplantation. |
2007 |
Am. J. Transplant. |
pmid:17511670
|
Silva HT et al. |
One-year results with extended-release tacrolimus/MMF, tacrolimus/MMF and cyclosporine/MMF in de novo kidney transplant recipients. |
2007 |
Am. J. Transplant. |
pmid:17217442
|
Heffron TG et al. |
Once-daily tacrolimus extended-release formulation: 1-year post-conversion in stable pediatric liver transplant recipients. |
2007 |
Am. J. Transplant. |
pmid:17511684
|
Moench C et al. |
Tacrolimus monotherapy without steroids after liver transplantation--a prospective randomized double-blinded placebo-controlled trial. |
2007 |
Am. J. Transplant. |
pmid:17511685
|
Bunnapradist S et al. |
Conversion from twice-daily tacrolimus to once-daily extended release tacrolimus (LCPT): the phase III randomized MELT trial. |
2013 |
Am. J. Transplant. |
pmid:23279614
|
Ceschi A et al. |
Acute calcineurin inhibitor overdose: analysis of cases reported to a national poison center between 1995 and 2011. |
2013 |
Am. J. Transplant. |
pmid:23279718
|
Tedesco-Silva H et al. |
Reduced Incidence of Cytomegalovirus Infection in Kidney Transplant Recipients Receiving Everolimus and Reduced Tacrolimus Doses. |
2015 |
Am. J. Transplant. |
pmid:25988935
|
Pech T et al. |
Intestinal regeneration, residual function and immunological priming following rescue therapy after rat small bowel transplantation. |
2012 |
Am. J. Transplant. |
pmid:22974463
|
Kaplan B and Kirk AD |
Tacrolimus and sirolimus: when bad things happen to good drugs. |
2006 |
Am. J. Transplant. |
pmid:16827845
|
McAlister VC et al. |
Cyclosporin versus tacrolimus as primary immunosuppressant after liver transplantation: a meta-analysis. |
2006 |
Am. J. Transplant. |
pmid:16827858
|
Gallon L et al. |
Long-term renal allograft function on a tacrolimus-based, pred-free maintenance immunosuppression comparing sirolimus vs. MMF. |
2006 |
Am. J. Transplant. |
pmid:16827862
|
Grenda R et al. |
A prospective, randomized, multicenter trial of tacrolimus-based therapy with or without basiliximab in pediatric renal transplantation. |
2006 |
Am. J. Transplant. |
pmid:16827869
|
Vanhove T et al. |
High Intrapatient Variability of Tacrolimus Concentrations Predicts Accelerated Progression of Chronic Histologic Lesions in Renal Recipients. |
2016 |
Am. J. Transplant. |
pmid:27013142
|
Posselt AM et al. |
Islet transplantation in type 1 diabetics using an immunosuppressive protocol based on the anti-LFA-1 antibody efalizumab. |
2010 |
Am. J. Transplant. |
pmid:20659093
|
Teuteberg JJ et al. |
Alemtuzumab induction prior to cardiac transplantation with lower intensity maintenance immunosuppression: one-year outcomes. |
2010 |
Am. J. Transplant. |
pmid:19889126
|
Echeverri GJ et al. |
Endoscopic gastric submucosal transplantation of islets (ENDO-STI): technique and initial results in diabetic pigs. |
2009 |
Am. J. Transplant. |
pmid:19775318
|
Gaston RS et al. |
Fixed- or controlled-dose mycophenolate mofetil with standard- or reduced-dose calcineurin inhibitors: the Opticept trial. |
2009 |
Am. J. Transplant. |
pmid:19459794
|
Irish WD et al. |
Cyclosporine versus tacrolimus treated liver transplant recipients with chronic hepatitis C: outcomes analysis of the UNOS/OPTN database. |
2011 |
Am. J. Transplant. |
pmid:21564522
|
Barbas AS et al. |
Posterior reversible encephalopathy syndrome independently associated with tacrolimus and sirolimus after multivisceral transplantation. |
2013 |
Am. J. Transplant. |
pmid:23331705
|
Gatault P et al. |
Reduction of Extended-Release Tacrolimus Dose in Low-Immunological-Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor-Specific Antibodies: A Randomized Study. |
2017 |
Am. J. Transplant. |
pmid:27862923
|
Miller LW |
Cardiovascular toxicities of immunosuppressive agents. |
2002 |
Am. J. Transplant. |
pmid:12392286
|
Brennan DC et al. |
Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. |
2005 |
Am. J. Transplant. |
pmid:15707414
|
Rogers J et al. |
Effect of ethnicity on outcome of simultaneous pancreas and kidney transplantation. |
2003 |
Am. J. Transplant. |
pmid:14510702
|